Hannah Joseph Hospital Limited (BOM:544687)
India · Delayed Price · Currency is INR 108.50
-2.80 (-2.52%)
At close: Aug 21, 2026
Hannah Joseph Hospital Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 920.52 | 775.31 | 634.08 | 546.23 | 580.97 |
Other Revenue | - | - | - | 0.62 | 0.68 |
| 920.52 | 775.31 | 634.08 | 546.85 | 581.65 | |
Revenue Growth | 18.73% | 22.27% | 15.95% | -5.98% | 63.13% |
Cost of Revenue | 270.18 | 233.22 | 178.29 | 182.14 | 207.25 |
Gross Profit | 650.34 | 542.09 | 455.79 | 364.71 | 374.4 |
Selling, General & Admin | 47.25 | 28.99 | 20.31 | 17.99 | 18.58 |
Other Operating Expenses | 351.11 | 306.19 | 254.15 | 180.7 | 172.93 |
Operating Expenses | 465.82 | 407.6 | 356.59 | 292.16 | 300.14 |
Operating Income | 184.51 | 134.49 | 99.2 | 72.56 | 74.26 |
Interest Expense | -26.94 | -33.01 | -46.41 | -62.45 | -69.26 |
Interest & Investment Income | 2.6 | 2.46 | 0.49 | 0.21 | 0.1 |
Other Non Operating Income (Expenses) | 0 | -0.47 | -0.12 | -1.89 | -1.7 |
EBT Excluding Unusual Items | 160.18 | 103.48 | 53.17 | 8.43 | 3.41 |
Gain (Loss) on Sale of Assets | 0.17 | -0.01 | 0.27 | -0.19 | - |
Other Unusual Items | - | - | - | 1.9 | - |
Pretax Income | 160.35 | 103.47 | 53.43 | 10.15 | 3.41 |
Income Tax Expense | 48.54 | 31.37 | 12.77 | 0.05 | 0.03 |
Net Income | 111.81 | 72.1 | 40.67 | 10.11 | 3.39 |
Net Income to Common | 111.81 | 72.1 | 40.67 | 10.11 | 3.39 |
Net Income Growth | 55.08% | 77.30% | 302.43% | 198.52% | - |
Shares Outstanding (Basic) | 18 | 17 | 17 | 13 | 4 |
Shares Outstanding (Diluted) | 18 | 17 | 17 | 13 | 4 |
Shares Change | 5.99% | 0.19% | 24.45% | 236.65% | 125.00% |
EPS (Basic) | 6.32 | 4.32 | 2.44 | 0.75 | 0.85 |
EPS (Diluted) | 6.32 | 4.32 | 2.44 | 0.75 | 0.85 |
EPS Growth | 46.32% | 76.96% | 223.37% | -11.33% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 60.36 | 72.8 | 56.9 | 38.06 | 147.95 |
Free Cash Flow Per Share | 3.41 | 4.36 | 3.41 | 2.84 | 37.19 |
Dividend Per Share | 2.000 | - | - | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 70.65% | 69.92% | 71.88% | 66.69% | 64.37% |
Operating Margin | 20.04% | 17.35% | 15.65% | 13.27% | 12.77% |
Profit Margin | 12.15% | 9.30% | 6.41% | 1.85% | 0.58% |
Free Cash Flow Margin | 6.56% | 9.39% | 8.97% | 6.96% | 25.44% |
EBITDA | 236.37 | 193.17 | 168.47 | 166.03 | 182.89 |
EBITDA Margin | 25.68% | 24.91% | 26.57% | 30.36% | 31.44% |
D&A For EBITDA | 51.86 | 58.67 | 69.27 | 93.47 | 108.62 |
EBIT | 184.51 | 134.49 | 99.2 | 72.56 | 74.26 |
EBIT Margin | 20.04% | 17.35% | 15.65% | 13.27% | 12.77% |
Effective Tax Rate | 30.27% | 30.32% | 23.89% | 0.46% | 0.73% |
Revenue as Reported | 925.59 | 779.01 | - | 548.97 | 581.75 |
Advertising Expenses | 30.55 | 12.38 | 3.93 | 2.95 | 3.82 |